Fierce Biotech News & Reports
网页Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Fierce Biotech Layoff Tracker 2024
网页2 天之前 · July 31 - HilleVax: The clinical-stage vaccine biotech is laying off 41 employees, or approximately 40% of the company’s workforce, to cut down on costs. The saved cash is supposed to help ...
Biotech | Fierce Biotech
网页2024年8月20日 · Shortly after a positive data drop for Eli Lilly’s efsitora, the Indianapolis-based company is again padding the case for its weekly insulin prospect. Fraiser Kansteiner Sep 11, 2024 2:05pm ...
Introducing Fierce Biotech's 2024 Fierce 15
网页2024年8月5日 · One of our Fierce 15 honorees dove deep into the ocean for inspiration from the sea squirt to develop new human therapeutics. Another thought the adorable 13-lined ground squirrel, with its polka ...
Introducing Fierce Biotech's 2023 Fierce 15
网页2023年8月28日 · The latest crop of Fierce 15 honorees consists of companies pushing the envelope not only in the lab, in the clinic or on the conference circuit—they are also defining what it means to be a ...
Fierce Biotech's 2022 Fierce 15
网页2022年9月12日 · Fierce Biotech's 2022 Fierce 15. By Ben Adams Sep 12, 2022 12:00am. Fierce 15 AgomAb Therapeutics AviadoBio Amphista Therapeutics. This year we focused more than ever before on diversity in ...
Fierce 15: Where are they now? - Fierce Biotech
网页2024年7月26日 · In this week’s episode of "The Top Line," Fierce Biotech’s Annalee Armstrong highlights some of the most promising companies that made our prestigious Fierce 15 list back in 2014.
Fierce Biotech's 2021 Fierce 15
网页While speaking to a number of venture capitalists this year, we picked their brains on how to choose life science winners. It’s never an easy task, and the pandemic has made things much harder ...
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
网页4 天之前 · Novo Nordisk bets $600M biobucks on NanoVation's ability to take genetic medicines beyond the liver. Novo Nordisk is continuing its push into genetic medicines, agreeing to pay NanoVation ...
F2G raises $100M for 2nd attempt to get new antifungal to market
网页2024年9月12日 · F2G raises $100M to fund 2nd attempt to get new antifungal class to market. After F2G’s first attempt to get a brand-new class of antifungal to market was derailed by the FDA, the U.K.-based ...
跳至内容